Armm Competitors

ARMM Stock

USD 0.0009 0.00 0.00%

Armm Inc competes with Abbott Laboratories, Stryker, Boston Scientific, Medtronic PLC, and Siemens Healthineers; as well as few others. The company conducts business under Healthcare sector and is part of Medical Devices industry. Analyzing Armm competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Armm to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Armm Correlation with its peers.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Armm competition on your existing holdings.

Specify up to 10 symbols:

Hype

Prediction

Low	Estimated	High
0.00	0.0009	0.00

Details

Intrinsic

Valuation

Low	Real	High
0.00	0.0008	0.00

Details

Armm Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Armm and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Armm and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Armm Inc does not affect the price movement of the other competitor.

	ABT	SYK	BSX	MDT	SMMNY	EW	DXCM	PHG	STE
ABT		0.71	0.75	0.66	-0.38	0.05	-0.07	-0.07	-0.28	ABT
SYK	0.71		0.71	0.53	-0.39	-0.19	-0.06	-0.34	-0.17	SYK
BSX	0.75	0.71		0.62	-0.23	-0.19	-0.17	-0.02	-0.56	BSX
MDT	0.66	0.53	0.62		-0.11	0.12	-0.23	0.22	-0.08	MDT
SMMNY	-0.38	-0.39	-0.23	-0.11		0.11	-0.19	0.64	0.29	SMMNY
EW	0.05	-0.19	-0.19	0.12	0.11		0.54	0.16	-0.03	EW
DXCM	-0.07	-0.06	-0.17	-0.23	-0.19	0.54		-0.34	-0.31	DXCM
PHG	-0.07	-0.34	-0.02	0.22	0.64	0.16	-0.34		0.36	PHG
STE	-0.28	-0.17	-0.56	-0.08	0.29	-0.03	-0.31	0.36		STE
	ABT	SYK	BSX	MDT	SMMNY	EW	DXCM	PHG	STE

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

High positive correlations

BSX	+ 0.75	ABT
SYK	+ 0.71	ABT
BSX	+ 0.71	SYK
MDT	+ 0.66	ABT
PHG	+ 0.64	SMMNY
MDT	+ 0.62	BSX

High negative correlations

STE	- 0.56	BSX
SMMNY	- 0.39	SYK
SMMNY	- 0.38	ABT
PHG	- 0.34	DXCM
PHG	- 0.34	SYK
STE	- 0.31	DXCM

Risk-Adjusted Indicators

There is a big difference between Armm Pink Sheet performing well and Armm Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Armm's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ABT	0.78	0.03	(0.06)	0.21	0.86	(0.82)	1.40	(1.29)	5.90
SYK	0.80	0.15	0.08	0.46	0.83	(0.90)	1.66	(1.73)	4.70
BSX	0.65	0.14	0.09	0.42	0.58	(0.73)	1.52	(0.89)	4.60
MDT	0.76	0.02	(0.04)	0.18	0.93	(0.77)	2.33	(1.63)	4.94
SMMNY	1.10	(0.12)	0.00	(0.25)	0.00	0.00	3.82	(2.10)	8.08
EW	1.23	(0.04)	(0.09)	(0.02)	1.54	(1.23)	2.20	(2.36)	8.56
DXCM	1.67	0.05	(0.01)	0.23	1.82	(2.02)	4.07	(2.81)	10.30
PHG	1.28	(0.13)	0.00	1.67	0.00	0.00	2.23	(1.94)	19.65
STE	0.85	(0.12)	0.00	(0.22)	0.00	0.00	1.71	(2.07)	8.04

Unable to evaluate fundamental data of [ABT, SYK, BSX, MDT, SMMNY, EW, DXCM, PHG, STE] at this time. Please try again later

All Fundamental Data

Armm Competitive Analysis

The better you understand Armm competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Armm's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Armm's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	ARMM	ABT	SYK	BSX	MDT	SMMNY	EW	DXCM	PHG	STE
	0.00 0.0009 Armm	0.61 115.03 Abbott	1.30 383.28 Stryker	1.33 87.59 Boston	2.24 86.00 Medtronic	1.83 26.26 Siemens	0.54 66.16 Edwards	2.96 74.68 DexCom	0.85 25.74 Koninklijke	0.49 221.19 STERIS
Market Volatility (90 Days Market Risk)	Very steady	Very steady	Very steady	Very steady	Very steady	Very steady	Very steady	Very steady	Not too volatile	Very steady
Market Performance (90 Days Performance)	Very Weak	Insignificant	Good	Solid	Insignificant	Very Weak	Very Weak	Very Weak	Very Weak	Very Weak
Odds of Financial Distress (Probability Of Bankruptcy)	Low	Very Low	Very Low	Very Small	Low	Low	Very Low	Very Small	Below Average	Very Low
Current Valuation (Equity Enterprise Value)	Over Valued	Fairly Valued	Fairly Valued	Over Valued	Fairly Valued	Fairly Valued	Under Valued	Under Valued	Over Valued	Over Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Strong Buy	Strong Buy	Strong Buy	Buy	Not Available	Buy	Strong Buy	Buy	Buy
Trade Advice (90 Days Macroaxis Advice)	Strong Sell	Cautious Hold	Strong Hold	Strong Hold	Strong Hold	Cautious Hold	Sell	Cautious Hold	Sell	Hold
Current Ratio	N/A	1.86	2.0	1.45	1.76	1.01	3.83	3.77	1.19	2.03
Net Asset	N/A	73.21 B	39.91 B	35.14 B	89.98 B	49.06 B	9.36 B	6.26 B	29.41 B	11.06 B
Profit Margin	N/A	0.14	0.16	0.11	0.12	0.0918	0.66	0.17	-0.0182	0.0816
EBITDA	N/A	10.46 B	5.16 B	3.45 B	9.06 B	4.26 B	1.53 B	916.7 M	1.04 B	1.41 B
Operating Margin	N/A	0.19	0.22	0.17	0.18	0.13	0.29	0.15	0.0772	0.17
Current Valuation	N/A	207.94 B	156.91 B	137.85 B	130.33 B	59.39 B	35.49 B	28.43 B	31.04 B	24.06 B
Price To Book	N/A	5.04	7.35	6.32	2.35	3.16	4.11	14.32	1.9	3.33
Retained Earnings	N/A	37.55 B	16.77 B	819 M	30.4 B	N/A	8.99 B	1.02 B	5.4 B	2.09 B
Current Asset	N/A	14.15 B	1.15 B	1.21 B	23.6 B	N/A	2.05 B	231.3 M	13.25 B	972.52 M
Five Year Return	N/A	1.54	1.07	N/A	2.18	N/A	N/A	N/A	2.64	0.96
Beta	N/A	0.72	0.92	0.8	0.85	0.61	1.12	1.17	0.79	0.85
Number Of Employees	2	114 K	52 K	48 K	95 K	70.1 K	19.8 K	9.5 K	69.28 K	18 K
Shares Outstanding	N/A	1.73 B	381.22 M	1.47 B	1.28 B	2.24 B	589.8 M	390.6 M	931.89 M	98.71 M
Cash Flow From Operations	N/A	7.26 B	3.71 B	2.5 B	6.79 B	2.5 B	895.8 M	748.5 M	2.14 B	973.27 M
Annual Yield	N/A	0.0191	0.0082	N/A	0.0318	0.0178	N/A	N/A	N/A	0.0103
Total Debt	N/A	15.87 B	12.99 B	9.49 B	26.05 B	15 M	694.9 M	2.59 B	7.61 B	3.38 B
Return On Equity	N/A	0.15	0.19	0.0892	0.0795	0.11	0.19	0.32	-0.0459	0.0927
Return On Asset	N/A	0.0649	0.0711	0.049	0.0442	0.0383	0.11	0.0606	0.0136	0.0545
Number Of Shares Shorted	N/A	14.07 M	4.05 M	12.91 M	10.18 M	N/A	7.7 M	9.36 M	2.58 M	1.03 M
Book Value Per Share	N/A	22.94	52.86	14.05	37.39	8.39	16.18	5.07	12.72	66.8
Current Liabilities	N/A	9.19 B	707.5 M	923 M	7.17 B	N/A	476.2 M	66.9 M	9.17 B	400.61 M
Total Asset	N/A	73.21 B	39.91 B	35.14 B	89.98 B	49.06 B	9.36 B	6.26 B	29.41 B	11.06 B
Debt To Equity	N/A	0.46	0.88	0.51	0.51	0.85	0.11	1.17	0.54	0.5
Short Ratio	N/A	2.83	3.89	1.91	2.19	N/A	1.31	1.97	2.9	2.1
Target Price	N/A	129.66	395.88	97.0	96.22	30.96	76.39	95.31	34.5	249.39
Last Dividend Paid	N/A	2.2	3.2	N/A	2.77	0.95	N/A	N/A	0.85	2.13
Shares Owned By Institutions	N/A	78.15	80.14	92.44	84.52	N/A	85.81	98.69	6.93	99.81
Market Capitalization	N/A	199.51 B	146.11 B	129.09 B	110.3 B	63.44 B	39.02 B	29.17 B	24.34 B	21.83 B
Price To Earning	N/A	24.14	63.07	107.05	20.44	28.75	32.77	245.31	33.57	36.93
Price To Earnings To Growth	N/A	2.25	2.71	1.61	1.63	2.57	6.1	1.13	0.36	1.29
Price To Sales	N/A	4.84	6.65	8.11	3.39	2.66	6.18	7.38	1.35	4.1
Net Income	N/A	5.72 B	3.17 B	1.59 B	3.68 B	2.04 B	1.4 B	541.5 M	(453 M)	380.08 M
Earnings Per Share	N/A	3.29	9.2	1.19	2.91	0.97	2.59	1.7	-0.51	5.93
Shares Owned By Insiders	N/A	0.53	5.37	0.17	0.25	N/A	0.91	0.31	N/A	0.29
Revenue	N/A	40.11 B	20.5 B	14.24 B	32.36 B	21.71 B	6 B	3.62 B	18.17 B	5.14 B
Working Capital	N/A	8.83 B	4.6 B	1.58 B	11.15 B	N/A	2.84 B	2.87 B	1.66 B	1.94 B
Cash And Equivalents	N/A	9.88 B	1.84 B	928 M	1.54 B	1.37 B	769 M	2.37 B	1.17 B	208.36 M
Cash Per Share	N/A	5.68	2.98	0.24	8.59	0.61	2.81	6.14	1.43	3.16
Gross Profit	N/A	24.58 B	11.65 B	8.68 B	21.71 B	8.14 B	4.3 B	1.88 B	7.19 B	2.16 B
Day Typical Price	9.0E-4	115.35	386.13	88.05	86.68	26.31	66.56	74.07	25.82	222.02
Accumulation Distribution	N/A	38072.53	47444.92	92521.33	203062.0	0.011	109491.0	239065.0	6622.08	8116.63
Market Facilitation Index	N/A	N/A	0.0	N/A	N/A	0.29	N/A	0.0	N/A	0.0
Daily Balance Of Power	0.0	(0.61)	(0.49)	(0.73)	(0.88)	(1.69)	(0.19)	0.5335	(0.79)	(0.33)
Period Momentum Indicator	N/A	(0.71)	(5.06)	(1.18)	(1.97)	(0.49)	(0.36)	2.15	(0.22)	(1.08)
Rate Of Daily Change	1.0	0.99	0.99	0.99	0.98	0.98	0.99	1.03	0.99	1.0
Day Median Price	9.0E-4	115.51	387.55	88.29	87.03	26.34	66.76	73.77	25.86	222.44
Price Action Indicator	N/A	(0.84)	(6.80)	(1.28)	(2.01)	(0.32)	(0.78)	1.99	(0.23)	(1.79)
Coefficient Of Variation	N/A	1308.96	463.09	398.95	1095.6	(2,170)	32829.95	1817.67	(1,797)	(1,813)
Mean Deviation	N/A	0.7824	0.7956	0.654	0.7645	1.1	1.23	1.67	1.28	0.8508
Jensen Alpha	N/A	0.0288	0.1533	0.1391	0.0236	(0.12)	(0.04)	0.0488	(0.13)	(0.12)
Total Risk Alpha	N/A	(0.11)	0.0394	0.0592	(0.09)	(0.34)	(0.28)	(0.26)	(0.54)	(0.28)
Sortino Ratio	N/A	(0.06)	0.0836	0.0866	(0.04)	N/A	(0.09)	(0.01)	N/A	N/A
Downside Variance	N/A	0.9923	1.03	0.6908	1.15	N/A	2.44	3.52	N/A	N/A
Standard Deviation	N/A	1.08	1.03	0.8393	1.03	1.55	1.61	2.19	2.38	1.21
Kurtosis	N/A	4.22	0.5929	0.9473	0.6391	1.9	2.57	0.5058	30.1	4.72
Potential Upside	N/A	1.4	1.66	1.52	2.33	3.82	2.2	4.07	2.23	1.71
Treynor Ratio	N/A	0.2139	0.4562	0.4197	0.1785	(0.25)	(0.02)	0.23	1.67	(0.22)
Maximum Drawdown	N/A	5.9	4.7	4.6	4.94	8.08	8.56	10.3	19.65	8.04
Variance	N/A	1.16	1.07	0.7045	1.06	2.4	2.59	4.8	5.67	1.46
Market Risk Adjusted Performance	N/A	0.2239	0.4662	0.4297	0.1885	(0.24)	(0.01)	0.24	1.68	(0.21)
Risk Adjusted Performance	N/A	0.0612	0.1675	0.1923	0.0723	(0.03)	0.0076	0.0485	(0.04)	(0.04)
Skewness	N/A	0.8132	(0.01)	(0.41)	0.1252	0.826	0.5597	0.2853	(4.50)	(1.11)
Semi Deviation	N/A	0.8592	0.8329	0.5796	0.9298	N/A	1.54	1.82	N/A	N/A
Information Ratio	N/A	(0.05)	0.0821	0.0857	(0.04)	(0.14)	(0.08)	(0.01)	(0.11)	(0.17)
Value At Risk	N/A	(1.29)	(1.73)	(0.89)	(1.63)	(2.10)	(2.36)	(2.81)	(1.94)	(2.07)
Expected Short fall	N/A	(0.82)	(0.90)	(0.73)	(0.77)	N/A	(1.23)	(2.02)	N/A	N/A
Downside Deviation	N/A	0.9961	1.02	0.8312	1.07	N/A	1.56	1.88	N/A	N/A
Semi Variance	N/A	0.7381	0.6937	0.3359	0.8645	N/A	2.36	3.3	N/A	N/A

Armm Competition Performance Charts

Five steps to successful analysis of Armm Competition

Armm's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Armm Inc in relation to its competition. Armm's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of Armm in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Armm's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Armm Inc, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Armm position

In addition to having Armm in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Driverless Cars Thematic Idea Now

Driverless Cars

It encompasses large technology companies, automotive makers, security firms, and thematic ETFs across multiple industries. These entities are directly or indirectly involved in shaping the development and marketing of self-driving vehicles. The Driverless Cars theme has 36 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Driverless Cars Theme or any other thematic opportunities.

View All Next

Launch

Other Information on Investing in Armm Pink Sheet

Armm financial ratios help investors to determine whether Armm Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Armm with respect to the benefits of owning Armm security.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC